Hong Kong stock concept tracking | Domestic medical insurance negotiation is expected to yield results this week. Innovative drug industry leaders are receiving attention (Concept stocks attached).
After the "Implementation Plan to Support the Development of Innovative Drugs Throughout the Entire Chain" in this round of medical insurance negotiations, the first national medical insurance negotiations attracted much attention to the attitude towards innovative drugs.
Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.
①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?
Hong Kong stocks have fluctuated | Innovent Bio (01801) is currently up over 5% as the weight loss version of semaglutide is listed in China. The indication for weight loss of mazdutide is expected to be approved next year.
Innovent Bio (01801) is currently up over 5%, as of the time of this report, it has increased by 5.29%, priced at 37.8 Hong Kong dollars, with a transaction volume of 0.146 billion Hong Kong dollars.
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
Concept mining | Simgeglutide weight loss drug officially launched in China, multiple e-commerce platforms have gone online
The market has broad prospects
The new policy of prepayment of medical insurance fund has been released, and the pharmaceutical sector has ushered in a sharp rise. Experts believe it may be a way for medical institutions to release funding pressure.
On the 11th, the "Notice on Prepayment of Medical Insurance Fund" was issued, requiring the unified and improved basic medical insurance fund prepayment system at the national level. Experts believe that the prepayment system can effectively alleviate the problem of pharmaceutical industry debt, accelerate the turnover of funds for pharmaceutical companies. The medical sector showed a significant upward trend today, with listed companies attributing the rise to investor sentiment.
